Purchase Order 75N98026P01384
Award Date 9/3/26
Potential Completion Date 9/2/27
Potential Value $21K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, NH 03801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Human Genome Research Institute awarded a purchase order to Seqcoast Genomics, LLC for $21,400.32 on August 1, 2026. Work will be performed in Portsmouth, New Hampshire through July 31, 2027. The order supports the Laboratory of Julie Segre's studies of the human skin microbiome, involving preparation of skin commensal organisms from human skin and sequencing of their genomes for strain sharing studies. Pricing is firm fixed price with no small business set-aside applied.</p>
- <p>The National Human Genome Research Institute issued a $122,145.01 delivery order to Illumina, Inc. on September 15, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order has a firm fixed-price structure with an ultimate completion date of December 15, 2017. No set-aside was used.</p>
- <p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $15,314.69 on July 31, 2018, with final completion by August 29, 2018. The order is firm fixed price with no set-aside. Performance occurs in Bethesda, Maryland. The purchase order procures sequencing reagents, consumables, or related bioinformatics products from Illumina's core portfolio of DNA and RNA sequencing supplies and software.</p>
- <p>The National Human Genome Research Institute issued a $149,618.50 delivery order to Illumina, Inc., on September 1, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 30, 2017.</p>
- <p>The National Human Genome Research Institute issued a $98,905.32 delivery order to Illumina, Inc. on August 22, 2019, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order is firm fixed-price with an ultimate completion date of September 2, 2020. No set-aside was used.</p>
- The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $21,323.61 on June 29, 2017, with ultimate completion on July 28, 2017. No set-aside was used. Work is performed in Bethesda, Maryland. The order covers sequencing reagents, consumables, or related bioinformatics products under firm fixed pricing. The purchase order represents a simplified acquisition for commercial items within Illumina's established federal footprint of DNA and RNA sequencing...
- <p>The National Human Genome Research Institute issued a $15,321.60 delivery order to Illumina, Inc. on July 18, 2019, for genetic sequencing equipment and related genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 2, 2020. No set-aside was used for this award.</p>
- <p>The National Human Genome Research Institute issued a $13,029.68 delivery order to Illumina, Inc. on September 12, 2017, for genetic sequencing and genomic analysis equipment and supplies.</p> <p>Place of performance is North Bethesda, Maryland. The order has a firm fixed-price structure and an ultimate completion date of October 11, 2017. No set-aside was used.</p>
- <p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on November 28, 2017, with a ceiling value of $52,494.10 for genetic sequencing and genomic analysis technologies and services.</p> <p>Place of performance is Bethesda, MD 20892. The order was priced on a firm fixed-price basis with an ultimate completion date of September 2, 2020. No set-aside was used for this delivery order.</p>
- <p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $8,182.85 on August 15, 2017, with ultimate completion on September 14, 2017. Place of performance is Bethesda, Maryland. The order procures sequencing reagents, consumables, or related products under firm fixed price terms. No set-aside was applied.</p>